Pulished Date October, 2018
ID: 1486
Share on
Share on

The Point-Of-Care Diagnostics Market Is Predicted To Reach USD 36.16 Billion By 2023 With A CAGR Of 9.76 % According To Market Data Forecast Report.

Pulished: October, 2018
ID: 1486
Pages: 0

The Point-Of-Care Diagnostics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Point-Of-Care Diagnostics Market is estimated to be USD 22.7 billion in 2018 and predicted to rise to USD 36.16 billion by the end of 2023 with a CAGR of 9.76 %. The point-of- care diagnostics market is categorized based on products, end-users and mode of delivery. Products have been further segmented into Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, drugs of abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry and others. By End-Users, the market has been categorized as clinics, hospitals, home healthcare, ambulatory care settings, laboratories and others. Finally on the basis of delivery, the market has been segmented into OTC and prescription modes of delivery. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Key drivers such as advances in technology and introduction of cost effective and high quality medical solutions aimed at achieving miniaturization and lab automation, rising levels of patient awareness, Patients suffering from long-term diseases such as diabetes, are actively participating in the shift relating to the implementation of point-of-care diagnostic practices are propelling the growth of the market. Effort and co-ordination required among healthcare centers, researchers, practitioners and manufacturers, reluctance from the industry towards changing the existing norms, frequent product recalls, stringent regulatory framework and unfavorable reimbursement scenario are the major restraints that limiting the growth of the dental device market.

North America is predicted to dominate the overall market in the next five years due to the presence of premium healthcare infrastructure, the presence of high levels of awareness amongst the patient population base as well as the physicians associated with fast disease diagnosis, established reimbursement framework and high healthcare affordability in this region. However, emerging markets such as China, India offer high growth potential for companies involved in the development and distribution of point-of- care diagnostic devices results to show high growth in Asia-Pacific region.

Major players that are dominating the Market are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton Dickinson and Company, Johnson & Johnson , Alere Inc., and PTS Diagnostics..

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-point-of-care-diagnostics-market-1559/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients